Originally posted by notyoueither
The problem could be that there are some socialised countries and some high-end insurance plans, and some very wealthy individuals...
So that there is a market that can afford to pay for a med for any condition. If only ten people suffer from the condition who are covered by 'any price coverage', then develop the drug and recoup the costs and make a profit off of the ten payers for those ten people.
There should be considerably more than ten people in Canada with this condition. Say there are 50. That's 40 million a year for meds for those 50 people. That's a lot of R&D money.
I agree with you. Junior should get his meds. I am questioning how they are priced.
The problem could be that there are some socialised countries and some high-end insurance plans, and some very wealthy individuals...
So that there is a market that can afford to pay for a med for any condition. If only ten people suffer from the condition who are covered by 'any price coverage', then develop the drug and recoup the costs and make a profit off of the ten payers for those ten people.
There should be considerably more than ten people in Canada with this condition. Say there are 50. That's 40 million a year for meds for those 50 people. That's a lot of R&D money.
I agree with you. Junior should get his meds. I am questioning how they are priced.
.Pay only a reasonable price for the drug but don't deny it to the kid on economic grounds ...... In fairness I am not sure why it is being denied. It may be red tape where the drug has not yet been approved ( for reasons unrelated to cost)
Comment